$1.54
0.65% yesterday
NYSE, May 20, 10:12 pm CET
ISIN
US68218J1034
Symbol
OABI
Sector
Industry

OmniAb Stock price

$1.54
-0.29 15.85% 1M
-2.36 60.51% 6M
-2.00 56.50% YTD
-2.85 64.92% 1Y
-7.25 82.48% 3Y
-7.25 82.48% 5Y
-7.25 82.48% 10Y
NYSE, Closing price Tue, May 20 2025
-0.01 0.65%
ISIN
US68218J1034
Symbol
OABI
Sector
Industry

Key metrics

Market capitalization $186.36m
Enterprise Value $165.24m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.18
P/S ratio (TTM) P/S ratio 6.97
P/B ratio (TTM) P/B ratio 0.69
Revenue growth (TTM) Revenue growth 27.07%
Revenue (TTM) Revenue $26.74m
EBIT (operating result TTM) EBIT $-71.39m
Free Cash Flow (TTM) Free Cash Flow $-39.66m
Cash position $43.60m
EPS (TTM) EPS $-0.59
P/E forward negative
P/S forward 8.15
EV/Sales forward 7.23
Short interest 8.68%
Show more

Is OmniAb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

OmniAb Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a OmniAb forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a OmniAb forecast:

Buy
100%

Financial data from OmniAb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
27 27
27% 27%
100%
- Direct Costs 21 21
6% 6%
77%
6.07 6.07
316% 316%
23%
- Selling and Administrative Expenses 3.62 3.62
54% 54%
14%
- Research and Development Expense 53 53
7% 7%
199%
-51 -51
20% 20%
-190%
- Depreciation and Amortization 21 21
6% 6%
77%
EBIT (Operating Income) EBIT -71 -71
14% 14%
-267%
Net Profit -61 -61
3% 3%
-229%

In millions USD.

Don't miss a Thing! We will send you all news about OmniAb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OmniAb Stock News

Neutral
Business Wire
7 days ago
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced its participation in the 21st Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omni Hotel. Earlier today, the company showcased case studies utilizing xPloration, a high-throughput single B-cell screening platform that harnesses machine learning and computer vision artificial...
Neutral
Seeking Alpha
11 days ago
OmniAb, Inc. (NASDAQ:OABI ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Kurt Gustafson - Chief Financial Officer Matthew Foehr - Chief Executive Officer Bob Chen - Vice President, Discovery Systems Conference Call Participants Michael Almisry - Leerink Partners Alexander Xenakis - Truist Securities Joseph Pantginis - H.C. Wainwright Jacqueline Kisa - TD Cowen Op...
Neutral
Business Wire
12 days ago
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program updates. “We have started the year with robust deal flow, including both platform and asset-based deals. Our business remains strong as our diversified pipeline of partner programs is progressing with recent and e...
More OmniAb News

Company Profile

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Head office United States
CEO Matthew Foehr
Employees 114
Founded 2015
Website www.omniab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today